Patents/Assignees

ONECUREGEN CO., Ltd.

1 patent in portfolio

US12534436utility2026
Disubstituted Adamantyl Derivative or Pharmaceutically Acceptable Salt Thereof, and Pharmaceutical Composition for Suppressing Cancer Growth Comprising Same as Active Ingredient
0 cites